Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Appropriate study populations must be used
| The first 150 words of the full text of this article appear below. |
EDITOR
Otto et al describe significant differences in the serum
concentrations of S100 protein in patients with and without Creutzfeldt-Jakob disease.1 The population of patients
studied is, however, not appropriate for assessing the usefulness of
measuring serum concentrations of S100 protein as a diagnostic test,
and Otto et al's calculations of positive and negative predictive values of the test are invalid as they fail to take into consideration the prevalence of Creutzfeldt-Jakob disease as a cause of dementia.
Patients with clinically evident disease do not need a diagnostic test.
It is not informative to evaluate the potential of a blood test to
distinguish those with clinically definite Creutzfeldt-Jakob disease
from those without the disease on clinical grounds. The test is useful
only if it helps to predict the likelihood of the disease in a
population that does not meet the criteria for probable Creutzfeldt-Jakob disease, which is therefore the